NCGCs partners have contributed to the huge international effort on whole genome cancer genomics. Stian Knappskog (Lønnings group, UiB) and Ola Myklebost and collaborators (OUS/UiB) contributed data from paitents with breast cancer and osteosarcoma, respectively, and...
A database of Norwegian normal genetic variation As part of the NCGC studies of tumour mutations, we determine also the normal variants in blood samples from all patients. Since the detailed genetic profiles are very sensitive information, we will only...
The study by Løvf et al, “High degree of genomic heterogeneity in multifocal primary prostate cancer” is now in press in European Urology (Journal impact factor 17,6). This detailed study by the group of Rolf I Skotheim at the OUS Institute for...
After completion of our first two national projects, completing the exomes of tumours and normal tissue from more than 1000 patients, we have made a printed report, regrettably only in Norwegian. The report consists of an introduction to cancer genomics and...
The paper “Patterns of genomic evolution in advanced melanoma“, has been published in Nature Communications (Impact factor 13). This study from the group of Per Eystein Lønning in Bergen was the first we did, and illustrates the huge work required to...
Personalised medicine, or precision medicine, is when we can better adapt disease treatment to the genetics of each patient and molecular subtype of the disease The recent development of high-throughput DNA sequencing hs enabled us to analyse in molecular...
